Circulating MicroRNAs Associated with Incident End-Stage Renal Disease in Chinese with Type 2 Diabetes

被引：0
|
作者：
Fan, Baoqi
Lee, Heung Man
Lim, Cadmon K. P.
Choy, Richard
Chan, Juliana C.
Luk, Andrea
Ma, Ronald C.
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-519-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Clinical predictive factors and prediction models for end-stage renal disease in Chinese patients with type 2 diabetes mellitus
    Gao, Yueming
    Shang, Zhi
    Nie, Sheng
    Feng, Songtao
    Wang, Bin
    Li, Zuolin
    Wu, Min
    Wen, Yi
    Xu, Hong
    Weng, Jianping
    Chen, Chunbo
    Liu, Huafeng
    Yang, Qiongqiong
    Li, Hua
    Kong, Yaozhong
    Li, Guisen
    Wan, Qijun
    Zha, Yan
    Hu, Ying
    Xu, Gang
    Shi, Yongjun
    Zhou, Yilun
    Su, Guobin
    Tang, Ying
    Gong, Mengchun
    Fan, Hou Fan
    Liu, Bicheng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (07):
  • [22] End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry
    X. L. Yang
    W. Y. So
    A. P. S. Kong
    P. Clarke
    C. S. Ho
    C. W. K. Lam
    M. H. L. Ng
    R. R. Lyu
    D. D. Yin
    C. C. Chow
    C. S. Cockram
    P. C. Y. Tong
    J. C. N. Chan
    Diabetologia, 2006, 49
  • [23] End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong diabetes registry
    Yang, X. L.
    So, W. Y.
    Kong, A. P. S.
    Clarke, P.
    Ho, C. S.
    Lam, C. W. K.
    Ng, M. H. L.
    Lyu, R. R.
    Yin, D. D.
    Chow, C. C.
    Cockram, C. S.
    Tong, P. C. Y.
    Chan, J. C. N.
    DIABETOLOGIA, 2006, 49 (10) : 2299 - 2308
  • [24] Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes
    Paykov, Meda E.
    Nelson, Robert G.
    Knowler, William C.
    Cheng, Yiling
    Krolewski, Andrzej S.
    Niewczas, Monika A.
    KIDNEY INTERNATIONAL, 2015, 87 (04) : 812 - 819
  • [25] Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease
    E. Villar
    K. R. Polkinghorne
    S. H. Chang
    S. J. Chadban
    S. P. McDonald
    Diabetologia, 2009, 52 : 2536 - 2541
  • [26] Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease
    Villar, E.
    Polkinghorne, K. R.
    Chang, S. H.
    Chadban, S. J.
    McDonald, S. P.
    DIABETOLOGIA, 2009, 52 (12) : 2536 - 2541
  • [27] Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
    Zhao, Lijun
    Zou, Yutong
    Zhang, Junlin
    Zhang, Rui
    Ren, Honghong
    Lin, Li
    Guo, Ruikun
    Zhang, Jie
    Liu, Fang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (14): : 2113 - 2124
  • [28] The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus
    Postma, Maarten J.
    de Zeeuw, Dick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) : 2975 - 2983
  • [29] Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease
    Sakai Y.
    Sakai S.
    Mugishima K.
    Katayama A.
    Sumi Y.
    Otsuka Y.
    Otsuka T.
    Tsuruoka S.
    Renal Replacement Therapy, 3 (1)
  • [30] Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
    Niewczas, Monika A.
    Sirich, Tammy L.
    Mathew, Anna V.
    Skupien, Jan
    Mohney, Robert P.
    Warram, James H.
    Smiles, Adam
    Huang, Xiaoping
    Walker, Walker
    Byun, Jaeman
    Karoly, Edward D.
    Kensicki, Elizabeth M.
    Berry, Gerard T.
    Bonventre, Joseph V.
    Pennathur, Subramaniam
    Meyer, Timothy W.
    Krolewski, Andrzej S.
    KIDNEY INTERNATIONAL, 2014, 85 (05) : 1214 - 1224
12345